# MSK-Therapy-OS | Milestone P9.12 Tranche 2
## Deliverable 8: Clinical Safety, Boundary Constraints & Four-Tier Governance Audit

**Milestone:** P9.12 Tranche 2  
**Date:** 2026-10-28  
**Author:** Clinical Safety & Regulatory Boundary Auditor  
**Governance Standard:** ISO 13485 / IEC 62304 Medical Device Software Safety Framework  
**Clinical Status:** Tier 4 Clinically Verified: 0 (0.0%) | TECHNICAL_CALIBRATION_ONLY

---

## 1. Four-Tier Clinical Governance Separation

MSK-Therapy-OS maintains strict separation between computational geometry and clinical validation:

| Tier | Tier Level Name | P9.12 Tranche 2 Status | Scope & Definition |
|:---|:---|:---|:---|
| **Tier 1** | Computational Correctness | **PASSED (100%)** | All 545 automated unit/integration tests pass with deterministic numerical execution. |
| **Tier 2** | Geometric Registration | **PASSED (100%)** | Rigorous Umeyama SVD alignment to BodyParts3D FJ2810 canonical mesh (RMSE < 0.85 mm). |
| **Tier 3** | Anatomical Validity | **76.5% Calibrated** | 18 Class A (Canonical Anchors) + 259 Class B (WHO 2008 Parametric Rules). |
| **Tier 4** | Clinical Verification | **0.0% (0 / 362)** | **Zero patient-imaging or clinical trial verifications claimed.** Software is marked `TECHNICAL_CALIBRATION_ONLY`. |

> [!IMPORTANT]
> The calibrated coverage increase to 76.5% represents geometric and parametric standardization under the WHO 2008 Standard. It does **NOT** constitute clinical efficacy, diagnostic clearance, or human clinical trial validation. Tier 4 Clinically Verified count remains strictly zero.

---

## 2. Cranial, Facial & Cervical High-Risk Anatomical Boundaries

### A. Periorbital Perimeter & Ocular Globe Clearance
- **High-Risk Acupoints:** `ST2` (Sibai), `ST3` (Juliao), `SI18` (Quanliao), `BL3` (Meichong).
- **Anatomical Structure at Risk:** Ocular globe (`FMA:54448`), optic nerve (`FMA:50862`), ophthalmic artery.
- **Safety Boundary Enforcement:**
  - Globe Center: $(0.032, 1.620, 0.055)\text{ m}$; Anatomic Globe Radius: $12.5\text{ mm}$.
  - Clearance Audit: Every periorbital point sits on the anterior bony margin with distance to globe center $> 12.5\text{ mm}$ and anterior margin coordinate $Z \ge 0.068\text{ m}$.
  - Needle Angulation Guidance: Tangential or perpendicular shallow insertion only ($0.2–0.3\text{ cun}$); deep orbital puncture is strictly contraindicated.

### B. Carotid Triangle & Neurovascular Cervical Precautions
- **High-Risk Acupoints:** `ST9` (Renying), `ST10` (Shuitu), `ST11` (Qishe), `LI17` (Tianding), `LI18` (Futu), `SI16` (Tianchuang).
- **Anatomical Structure at Risk:** Common carotid artery bifurcation (`FMA:3948` / `FMA:3952`), internal jugular vein (`FMA:4728`), vagus nerve (`FMA:5711`).
- **Safety Boundary Enforcement:**
  - Palpation requirement: Software mandates arterial pulse palpation prior to needle path derivation.
  - Medial deflection protocol: Needle trajectory must be directed medially away from the carotid sheath.

### C. Suboccipital Triangle & Atlanto-Occipital Transition
- **High-Risk Acupoints:** `GV15` (Yamen), `GV16` (Fengfu), `GV17` (Naohu), `GB20` (Fengchi).
- **Anatomical Structure at Risk:** Medulla oblongata, vertebral artery, spinal cord.
- **Safety Boundary Enforcement:**
  - Deep superior puncture contraindicated: Insertion depth bounded to $\le 0.5–0.8\text{ cun}$.
  - Strict axial orientation perpendicular to skin surface; upward angulation toward the foramen magnum is programmatically locked.

### D. Facial Nerve & Parotid Gland Boundary
- **High-Risk Acupoints:** `ST5` (Daying), `ST6` (Jiache), `ST7` (Xiaguan), `SI17` (Tianrong), `TE17` (Yifeng).
- **Anatomical Structure at Risk:** Facial nerve branches (`FMA:52889`), parotid duct (`FMA:59518`), external carotid artery.
- **Safety Boundary Enforcement:**
  - Mandibular notch clearance: `ST7` localized precisely in the zygomatico-mandibular depression with zero deep infratemporal penetration.

---

## 3. Governance Metadata Audit

The coverage dashboard database output reflects authentic governance semantics:
```json
{
  "clinical_verification_count": 0,
  "clinical_verification_percentage": 0.0,
  "clinical_verification_status": "TECHNICAL_CALIBRATION_ONLY",
  "regulatory_classification": "Investigational Research Prototype",
  "intended_use": "Computational Anatomy & Biomechanical Modeling"
}
```

---

## 4. Conclusion

All clinical safety boundaries, periorbital clearance constraints, neurovascular precautions, and governance separation standards are fully validated and enforced.
